Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 26,270 shares at $9.06 ($238K) on 2022-02-09, disclosed to the SEC on 2022-02-10.
Open-market sale of $238k TEVA by Executive VP, European Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.06 | 13,135 | $119K | 50.0% |
| 2 | $9.06 | 13,135 | $119K | 50.0% |
| Total | $9.06 avg | 26,270 | $238K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |